SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 421 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $14,887,600 | +98096.7% | 130,000 | +18.2% | 0.83% | -16.4% |
| Q1 2023 | $15,161 | -41.5% | 110,000 | -45.0% | 1.00% | -42.4% |
| Q4 2022 | $25,916 | -99.9% | 200,000 | 0.0% | 1.73% | +12.2% |
| Q3 2022 | $22,108,000 | +323.8% | 200,000 | +185.7% | 1.54% | +1231.9% |
| Q1 2021 | $5,217,000 | -56.3% | 70,000 | 0.0% | 0.12% | -59.2% |
| Q4 2020 | $11,934,000 | -0.0% | 70,000 | -17.6% | 0.28% | -38.1% |
| Q3 2020 | $11,937,000 | -32.3% | 85,000 | -22.7% | 0.46% | -31.8% |
| Q2 2020 | $17,637,000 | +20.2% | 110,000 | -26.7% | 0.67% | -1.3% |
| Q1 2020 | $14,673,000 | -54.5% | 150,000 | -40.0% | 0.68% | -47.0% |
| Q4 2019 | $32,260,000 | +93.2% | 250,000 | +12.8% | 1.29% | +26.7% |
| Q3 2019 | $16,698,000 | -51.2% | 221,700 | -1.5% | 1.02% | -48.3% |
| Q2 2019 | $34,189,000 | -4.4% | 225,000 | -25.0% | 1.96% | -18.7% |
| Q1 2019 | $35,757,000 | +264.1% | 300,000 | +233.3% | 2.42% | +203.3% |
| Q4 2018 | $9,822,000 | – | 90,000 | – | 0.80% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 112,689 | $14,541,000 | 14.93% |
| Casdin Capital, LLC | 670,000 | $86,457,000 | 7.95% |
| Logos Global Management LP | 226,002 | $29,163,000 | 7.19% |
| Avoro Capital Advisors LLC | 1,760,000 | $227,110,000 | 6.67% |
| Camber Capital Management LP | 600,000 | $77,424,000 | 3.94% |
| STANSBERRY ASSET MANAGEMENT, LLC | 71,133 | $9,179,000 | 3.74% |
| Eventide Asset Management | 996,000 | $128,524,000 | 3.62% |
| CADIAN CAPITAL MANAGEMENT, LP | 550,000 | $70,972,000 | 3.14% |
| RTW INVESTMENTS, LP | 605,762 | $78,168,000 | 2.95% |
| Consonance Capital Management LP | 356,145 | $45,957,000 | 2.80% |